Navigation Links
Roka Bioscience Atlas System For Food Pathogen Detection Integrated At Department of Defense Food Analysis and Diagnostic Laboratory

WARREN, N.J., Sept. 25, 2013 /PRNewswire/ -- Roka Bioscience announced today the adoption of the Atlas System at the Department of Defense Food Analysis and Diagnostic Laboratory (FADL) at Fort Sam Houston in San Antonio, Texas. The FADL has implemented the Atlas System along with the Atlas Listeria Detection Assay and the Atlas Salmonella Detection Assay, both of which have received AOAC Performance Tested™ certification. The FADL plans to use the Atlas System for high-volume sample testing for Listeria and Salmonella in foods that are provided to all US armed forces around the world.


The Atlas System is an innovative fully automated molecular instrument for the detection of pathogens in food and environmental samples. This instrument utilizes a simple three-step procedure—Enrich, Transfer, Automate—and is capable of processing over 300 samples in 8 hours. The system's continuous workflow and high throughput provides greater efficiency, flexibility, and dynamic scalability to meet the ever-increasing demands placed on food safety laboratories.

The FADL protects the armed forces, ensuring food safety, fitness for consumption, and contractual compliance through microbiological, chemical, and toxicological testing of food and bottled water. The lab also provides technical consultation to the Department of Defense on integrating laboratory testing and food safety into science-based inspection systems.

"We are honored that the Department of Defense has chosen the Atlas System for its food safety testing," said Paul Thomas, CEO and President of Roka Bioscience. "With its high-throughput capabilities, accurate results, and unique technology, the Atlas System is ready for the important task of ensuring the food safety of our US troops domestically and overseas."

Roka Bioscience

Roka Bioscience is a privately held company focused on developing and commercializing innovative solutions based on molecular technologies for the industrial markets. The company's scientific platform is based on proven, proprietary technologies used widely in clinical diagnostic testing and now being introduced into food safety and other industrial markets. Roka's current product line provides food safety professionals with a fully automated molecular pathogen detection solution that delivers rapid, accurate results and improved laboratory efficiencies. For more information, visit


Steve Sobieski
Chief Financial Officer (908) 605-4621

SOURCE Roka Bioscience
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
2. SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
3. Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option
4. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
5. Sangamo BioSciences Proposes Public Offering Of Common Stock
6. Curemark CEO To Deliver Keynote Address at the BioScience Vision Summit
7. Nanoly Bioscience to Develop CU-Boulder Vaccine Stabilization Technology
8. Rancho BioSciences Partners with OmicSoft for Manual Data Curation
9. Regado Biosciences, Inc. Announces Exercise of Over-Allotment Option
10. Sanguine BioSciences Signs Agreements with More than 200 Partners to Enable Efficient Personalized Medicine Research
11. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):